SALL4 and cholangiocarcinoma: Similar to AY-Sall4 KOhepΔ, tumor-specific Bmi1 ablation significantly impaired AY-CCA formation, as assessed by prominently reduced gross CCA formation and LW/BW ratio (Fig. 4C and D).